MedPath

Fludrocortisone Acetate

Fludrocortisone Acetate Tablets, USP (0.1 mg) Rx only

Approved
Approval ID

96dbbf53-962b-49a4-a60d-91ae0b9fb9ff

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 3, 2022

Manufacturers
FDA

Novitium Pharma LLC

DUNS: 080301870

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fludrocortisone Acetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70954-252
Application NumberANDA215279
Product Classification
M
Marketing Category
C73584
G
Generic Name
Fludrocortisone Acetate
Product Specifications
Route of AdministrationORAL
Effective DateJune 3, 2022
FDA Product Classification

INGREDIENTS (6)

ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
FLUDROCORTISONE ACETATEActive
Quantity: 0.1 mg in 1 1
Code: V47IF0PVH4
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fludrocortisone Acetate - FDA Drug Approval Details